Therapeutic Advances in Musculoskeletal Disease

Journal Highlights

• Launched in 2009.
• Gold open access journal – all articles are made freely available online immediately upon publication.
• Rigorous peer review.
• Listed in PubMed and indexed in Science Citation Index Expanded (SCIE), Scopus, and ProQuest.
• A leading gold open access journal in musculoskeletal diseases.
• Over 300,000 full-text article views annually.

Therapeutic Advances in Musculoskeletal Disease is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of rheumatology, osteoporosis and related disciplines. Please see the aims and scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Musculoskeletal Disease promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the musculoskeletal disease community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/tamd.

Please see the submission guidelines tab for more information on how to submit your article to the journal.

Open access information

Unsolicited manuscripts submitted to Therapeutic Advances in Musculoskeletal Disease are subject to an article processing charge (APC) of $3,000 USD.

Articles are published under a Creative Commons licence and will be made openly available.

The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.

Contact

Please direct any queries to TAMusculoskeletalDisease@sagepub.com. This journal changed its publication mode from subscription to open access in 2019.